| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.51B | +4.2% |
| Cost of Revenue | $343.5M | +3.5% |
| Gross Profit | $1.16B | +4.5% |
| R&D Expense | $318.8M | +22.3% |
| SG&A Expense | $128.1M | +4.9% |
| Operating Income | $25.6M | -57.3% |
| Interest Expense | $78.0M | -41.1% |
| Income Tax | $19.5M | -19.0% |
| Net Income | -$53.7M | +46.3% |
| EPS (Basic) | -$0.19 | +52.5% |
| EPS (Diluted) | -$0.19 | +52.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $497.9M | +9.1% |
| Short-term Investments | $218.3M | +445.0% |
| Accounts Receivable | $454.8M | +5.2% |
| Current Assets | $1.40B | +19.4% |
| Total Assets | $4.97B | -0.3% |
| Current Liabilities | $963.5M | +2.3% |
| Long-term Debt | $1.84B | -0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $200.1M | -12.5% |
| Capital Expenditures | $5.5M | -49.5% |
| Investing Cash Flow | -$186.0M | -473.7% |
| Financing Cash Flow | $38.8M | +144.9% |
| Free Cash Flow | $194.6M | -10.7% |
| Total Liabilities |
| $2.92B |
| -2.9% |
| Stockholders' Equity | $2.05B | +3.6% |